Alanna C Morrison
Overview
Explore the profile of Alanna C Morrison including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
288
Citations
15418
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Kwak S, Hernandez-Cancela R, DiCorpo D, Condon D, Merino J, Wu P, et al.
Diabetes Care
. 2024 Apr;
47(6):1042-1047.
PMID: 38652672
Objective: To identify genetic risk factors for incident cardiovascular disease (CVD) among people with type 2 diabetes (T2D). Research Design And Methods: We conducted a multiancestry time-to-event genome-wide association study...
22.
Zhu X, Yang Y, Lorincz-Comi N, Li G, Bentley A, de Vries P, et al.
Nat Commun
. 2024 Apr;
15(1):3385.
PMID: 38649715
There is a long-standing debate about the magnitude of the contribution of gene-environment interactions to phenotypic variations of complex traits owing to the low statistical power and few reported interactions...
23.
Nagarajan P, Winkler T, Bentley A, Miller C, Kraja A, Schwander K, et al.
medRxiv
. 2024 Mar;
PMID: 38496537
Although both short and long sleep duration are associated with elevated hypertension risk, our understanding of their interplay with biological pathways governing blood pressure remains limited. To address this, we...
24.
de Vries P, Reventun P, Brown M, Heath A, Huffman J, Le N, et al.
Blood
. 2024 Feb;
143(18):1845-1855.
PMID: 38320121
Coagulation factor VIII (FVIII) and its carrier protein von Willebrand factor (VWF) are critical to coagulation and platelet aggregation. We leveraged whole-genome sequence data from the Trans-Omics for Precision Medicine...
25.
A polygenic risk score of atrial fibrillation improves prediction of lifetime risk for heart failure
Alkis T, Luo X, Wall K, Brody J, Bartz T, Chang P, et al.
ESC Heart Fail
. 2024 Jan;
11(2):1086-1096.
PMID: 38258344
Aims: Heart failure (HF) has shared genetic architecture with its risk factors: atrial fibrillation (AF), body mass index (BMI), coronary heart disease (CHD), systolic blood pressure (SBP), and type 2...
26.
Guirette M, Lan J, McKeown N, Brown M, Chen H, de Vries P, et al.
Hypertension
. 2024 Jan;
81(3):552-560.
PMID: 38226488
Background: The Dietary Approaches to Stop Hypertension (DASH) diet score lowers blood pressure (BP). We examined interactions between genotype and the DASH diet score in relation to systolic BP. Methods:...
27.
Hrytsenko Y, Shea B, Elgart M, Kurniansyah N, Lyons G, Morrison A, et al.
medRxiv
. 2024 Jan;
PMID: 38168328
We construct non-linear machine learning (ML) prediction models for systolic and diastolic blood pressure (SBP, DBP) using demographic and clinical variables and polygenic risk scores (PRSs). We developed a two-model...
28.
Armstrong N, Srinivasasainagendra V, Ammous F, Assimes T, Beitelshees A, Brody J, et al.
Front Genet
. 2024 Jan;
14:1278215.
PMID: 38162683
Apparent treatment-resistant hypertension (aTRH) is characterized by the use of four or more antihypertensive (AHT) classes to achieve blood pressure (BP) control. In the current study, we conducted single-variant and...
29.
Reventun P, Toledano-Sanz P, Alcharani N, Viskadourou M, Morrison A, Sabater-Lleal M, et al.
Blood Adv
. 2023 Dec;
8(1):143-149.
PMID: 38157226
No abstract available.
30.
Gallego-Fabrega C, Temprano-Sagrera G, Carcel-Marquez J, Muino E, Cullell N, Lledos M, et al.
J Thromb Haemost
. 2023 Dec;
22(4):936-950.
PMID: 38103737
Background: Thrombolytic recombinant tissue plasminogen activator (r-tPA) treatment is the only pharmacologic intervention available in the ischemic stroke acute phase. This treatment is associated with an increased risk of intracerebral...